Advanced cryptogenic fibrosing alveolitis: preliminary report on treatment with cyclosporin A

Respiratory Medicine

Volumn 83, Issue 4, 1989, Pages 277-279

  Alton, E W F W ^a   Johnson, M ^a   Turner Warwick, M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; HEART LUNG TRANSPLANTATION; HUMAN; LUNG DIFFUSION CAPACITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL;

EID: 0024417999     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(89)80196-9     Document Type: Article

References (4)

1. Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival
2. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis
3. Biological effects of cyclosporin A: a new antilymphocytic agent
4. Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies